Portfolio Holdings Detail for ISIN IE00BJ5JNZ06

Stock Name / Fund	iShares MSCI World Health Care Sector ESG UCITS ETF
Issuer	Blackrock
Entity holding fund	iShares V Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300QETNU1W5JY7Z94
ETF Ticker	CBUF.DE(EUR) CXE
ETF Ticker	WHCS.AS(USD) CXE
ETF Ticker	WHCS.MI(EUR) CXE
ETF Ticker	WHCS(EUR) ETF Plus

Holdings detail for MRK

Show aggregate MRK holdings

News associated with MRK

Surprising Analyst 12-Month Target For FDL

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-22 08:04:45

IWD, JNJ, MCD, MRK: Large Inflows Detected at ETF

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Russell 1000 Value ETF (Symbol: IWD) where we have detected an approximate $565.9 million dollar inflow -- that's a 0.9% increase week over w - 2025-09-18 13:26:06

Daiichi Sankyo, Merck Say Raludotatug Deruxtecan Granted Breakthrough Therapy Designation

(RTTNews) - Daiichi Sankyo Company Limited (DSKYF) and Merck & Co Inc. (MRK) said on Monday that the U.S. Food and Drug Administration (FDA) has granted breakthrough therapy designation for their raludotatug deruxtecan for the treatment of adults with platinum-resistant epithelia - 2025-09-15 08:43:59

Peter Lynch Detailed Fundamental Analysis - MRK

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-12 10:32:51

Guru Fundamental Report for MRK - Peter Lynch

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-11 10:33:21

Notable ETF Inflow Detected - VYM, JNJ, MRK, CME

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Vanguard High Dividend Yield ETF (Symbol: VYM) where we have detected an approximate $440.7 million dollar inflow -- that's a 0.7% increase week over - 2025-09-10 11:50:46

MRK Factor-Based Stock Analysis - Peter Lynch

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-10 10:34:14

Daiichi Sankyo And Merck : Ifinatamab Deruxtecan Shows Promising Results In Phase 2 ES-SCLC Trial

(RTTNews) - Daiichi Sankyo (DSKYF, 4568.T) and Merck & Co Inc. (MRK) announced that Results from the IDeate-Lung01 phase 2 trial showed that ifinatamab deruxtecan (I-DXd) demonstrated clinically meaningful response rates in patients with previously treated extensive-stage small c - 2025-09-08 02:18:22

Peter Lynch Detailed Fundamental Analysis - MRK

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-05 10:33:56

Pre-Market Most Active for Sep 5, 2025 : OPEN, TSLL, SCAG, SQQQ, MRK, NVDA, KO, AVGO, SNAP, FIG, WMT, NIO

The NASDAQ 100 Pre-Market Indicator is up 147.96 to 23,780.97. The total Pre-Market volume is currently 100,628,631 shares traded.The following are the most active stocks for the pre-market session: Opendoor Technologies Inc (OPEN) is +0.27 at $6.23, with 12,819,663 shares trade - 2025-09-05 09:29:53

Guru Fundamental Report for MRK - Peter Lynch

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-04 10:32:25

MRK Factor-Based Stock Analysis - Peter Lynch

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-03 10:34:47

Peter Lynch Detailed Fundamental Analysis - MRK

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-29 10:33:23

MRK's Strong Dividend History Helps it Reach 'Top Dividend Stock of the Dow'

Merck & Co Inc (Symbol: MRK) has been named as the ''Top Dividend Stock of the Dow'', according to Dividend Channel, which published its most recent ''DividendRank'' report. The report noted that among the components of the Dow Jones Industrial Average, MRK shares displayed b - 2025-08-28 08:50:04

MRK Factor-Based Stock Analysis - Peter Lynch

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-27 10:34:49

MRK Quantitative Stock Analysis - Peter Lynch

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-26 10:34:02

iShares MSCI ACWI ETF Experiences Big Outflow

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares MSCI ACWI ETF (Symbol: ACWI) where we have detected an approximate $429.5 million dollar outflow -- that's a 1.9% decrease week over week (f - 2025-08-25 13:36:45

Peter Lynch Detailed Fundamental Analysis - MRK

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-22 10:34:21

Dow Movers: WMT, MRK

In early trading on Thursday, shares of Merck topped the list of the day's best performing Dow Jones Industrial Average components, trading up 1.2%. Year to date, Merck has lost about 13.8% of its value. And the worst performing Dow component thus far on the day is Walmart, tr - 2025-08-21 11:27:42

MRK Factor-Based Stock Analysis - Peter Lynch

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-20 10:34:00

After Hours Most Active for Aug 19, 2025 : CSX, INTC, MRK, NVDA, IBN, KO, FUN, PEP, CX, WMT, HTZ, QQQ

The NASDAQ 100 After Hours Indicator is down -1.71 to 23,383.06. The total After hours volume is currently 259,932,235 shares traded.The following are the most active stocks for the after hours session: CSX Corporation (CSX) is -0.04 at $36.48, with 11,794,785 shares traded. Ove - 2025-08-19 17:24:59

Daiichi Sankyo Announces Breakthrough Therapy Designation For Ifinatamab Deruxtecan

(RTTNews) - Daiichi Sankyo announced that Ifinatamab deruxtecan has been granted Breakthrough Therapy Designation by the FDA for the treatment of adult patients with extensive-stage small cell lung cancer with disease progression on or after platinum-based chemotherapy. The FDA g - 2025-08-18 08:36:51

The Zacks Analyst Blog Highlights Merck, Palo Alto Networks, Freeport-McMoRan and Espey

Analysts spotlight Merck, Palo Alto Networks, Freeport-McMoRan, and Espey as innovation, contract wins, and industry trends shape growth prospects. - 2025-08-15 12:44:00

Noteworthy ETF Outflows: SUSL, MCD, DIS, MRK

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares ESG MSCI USA Leaders ETF (Symbol: SUSL) where we have detected an approximate $84.6 million dollar outflow -- that's a 8.7% decrease week ov - 2025-08-15 11:49:25

Peter Lynch Detailed Fundamental Analysis - MRK

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-15 10:31:59

Top Analyst Reports for Merck, Palo Alto & Freeport

Merck leans on Keytruda growth and pipeline expansion, Palo Alto rides subscription security demand, and Freeport benefits from electrification-driven copper demand. - 2025-08-14 17:46:00

Stocks See Support As Bessent Calls for a Big Rate Cut

The S&P 500 Index ($SPX ) (SPY ) on Wednesday rose +0.32%, the Dow Jones Industrials Index ($DOWI ) (DIA ) rose +1.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) rose +0.04%. September E-mini S&P futures (ESU25 ) rose +0.32%, and September E-mini Nasdaq futures (NQU25 ) fell... - 2025-08-14 15:15:33

MRK April 2026 Options Begin Trading

Investors in Merck & Co Inc (Symbol: MRK) saw new options become available today, for the April 2026 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 246 days until expiration the newly available contra - 2025-08-14 14:30:24

Stocks See Support As Bessent Calls for a Big Rate Cut

The S&P 500 Index ($SPX ) (SPY ) on Wednesday rose +0.32%, the Dow Jones Industrials Index ($DOWI ) (DIA ) rose +1.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) rose +0.04%. September E-mini S&P futures (ESU25 ) rose +0.32%, and September E-mini Nasdaq futures (NQU25 ) fell... - 2025-08-14 14:05:26

Stocks See Support As Bessent Calls for a Big Rate Cut

The S&P 500 Index ($SPX ) (SPY ) on Wednesday rose +0.32%, the Dow Jones Industrials Index ($DOWI ) (DIA ) rose +1.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) rose +0.04%. September E-mini S&P futures (ESU25 ) rose +0.32%, and September E-mini Nasdaq futures (NQU25 ) fell... - 2025-08-14 12:17:47

iShares MSCI World Health Care Sector ESG UCITS ETF MRK holdings

Date	Number of MRK Shares Held	Base Market Value of MRK Shares	Local Market Value of MRK Shares	Change in MRK Shares Held	Change in MRK Base Value	Current Price per MRK Share Held	Previous Price per MRK Share Held
2025-11-12 (Wednesday)	141,054	USD 12,899,388	USD 12,899,388	0	USD 70,527	USD 91.45	USD 90.95
2025-11-11 (Tuesday)	141,054	USD 12,828,861	USD 12,828,861	0	USD 592,426	USD 90.95	USD 86.75
2025-11-10 (Monday)	141,054	USD 12,236,435	USD 12,236,435	0	USD 66,296	USD 86.75	USD 86.28
2025-11-07 (Friday)	141,054	USD 12,170,139	USD 12,170,139	0	USD 70,527	USD 86.28	USD 85.78
2025-11-06 (Thursday)	141,054	USD 12,099,612	USD 12,099,612	0	USD 196,065	USD 85.78	USD 84.39
2025-11-05 (Wednesday)	141,054	USD 11,903,547	USD 11,903,547	3,370	USD 357,367	USD 84.39	USD 83.86
2025-11-04 (Tuesday)	137,684	USD 11,546,180	USD 11,546,180	3,370	USD 466,618	USD 83.86	USD 82.49
2025-11-03 (Monday)	134,314	USD 11,079,562	USD 11,079,562	0	USD -468,756	USD 82.49	USD 85.98
2025-10-31 (Friday)	134,314	USD 11,548,318	USD 11,548,318	0	USD -40,294	USD 85.98	USD 86.28
2025-10-30 (Thursday)	134,314	USD 11,588,612	USD 11,588,612	0	USD -40,294	USD 86.28	USD 86.58
2025-10-29 (Wednesday)	134,314	USD 11,628,906	USD 11,628,906	1,685	USD 86,204	USD 86.58	USD 87.03
2025-10-28 (Tuesday)	132,629	USD 11,542,702	USD 11,542,702	3,370	USD 167,910	USD 87.03	USD 88
2025-10-27 (Monday)	129,259	USD 11,374,792	USD 11,374,792	0	USD 65,922	USD 88	USD 87.49

Share Trades of MRK by Blackrock for IE00BJ5JNZ06

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-11-05	BUY	3,370	85.380	82.912	83.159	GBX 280,244	88.66
2025-11-04	BUY	3,370	84.960	82.035	82.328	GBX 277,444	88.68
2025-10-29	BUY	1,685	87.840	86.072	86.248	GBX 145,328	88.74
2025-10-28	BUY	3,370	88.105	86.930	87.048	GBX 293,350	88.75
2025-10-20	SELL	-1,685	87.000	85.030	85.227	GBX -143,607	88.79 Profit of 6,009 on sale
2025-10-16	BUY	1,692	85.500	83.600	83.790	GBX 141,773	88.84
2025-10-07	BUY	3,356	88.940	87.140	87.320	GBX 293,046	88.89
2025-09-26	BUY	5,037	78.960	77.694	77.821	GBX 391,984	89.01
2025-09-11	SELL	-3,358			85.150*		89.27 Profit of 299,762 on sale
2025-09-09	SELL	-8,395			84.610*		89.32 Profit of 749,856 on sale
2025-09-04	SELL	-3,358			84.050*		89.41 Profit of 300,223 on sale
2025-08-26	BUY	18,462			84.990*		89.53
2025-07-07	SELL	-2,904	81.540	80.150	80.289	GBX -233,159	89.97 Profit of 28,115 on sale
2025-06-17	BUY	1,447	80.700	78.190	78.441	GBX 113,504	90.84
2025-06-02	SELL	-5,824			76.250*		91.73 Profit of 534,237 on sale
2025-05-30	BUY	71,396			76.840*		91.84
2025-03-25	BUY	603			87.870*		97.65
2025-03-07	SELL	-1,211			94.650*		98.16 Profit of 118,867 on sale
2025-03-04	SELL	-608			92.560*		98.29 Profit of 59,760 on sale
2025-02-25	SELL	-609	93.060	90.440	90.702	GBX -55,238	98.76 Profit of 4,906 on sale
2025-02-20	SELL	-610	87.700	85.900	86.080	GBX -52,509	99.15 Profit of 7,973 on sale
2025-02-18	SELL	-609	83.590	81.040	81.295	GBX -49,509	99.58 Profit of 11,133 on sale
2025-02-04	BUY	524	91.230	87.330	87.720	GBX 45,965	101.80
2025-01-02	BUY	53,775	100.350	98.840	98.991	GBX 5,323,241	102.47
2024-12-10	BUY	54,891	103.770	100.750	101.052	GBX 5,546,845	102.50
2024-12-03	SELL	-608	102.450	100.620	100.803	GBX -61,288	102.47 Profit of 1,014 on sale
2024-11-29	SELL	-608	103.040	101.530	101.681	GBX -61,822	102.54 Profit of 519 on sale
2024-11-25	SELL	-609	101.740	99.510	99.733	GBX -60,737	102.59 Profit of 1,740 on sale
2024-11-22	SELL	-2,436	101.790	98.930	99.216	GBX -241,690	102.69 Profit of 8,450 on sale
2024-11-19	SELL	-610	97.550	95.260	95.489	GBX -58,248	103.12 Profit of 4,652 on sale
2024-11-18	SELL	-2,437	97.290	95.420	95.607	GBX -232,994	103.32 Profit of 18,798 on sale
2024-10-24	SELL	-1,218	106.620	105.260	105.396	GBX -128,372	106.45 Profit of 1,288 on sale
2024-10-24	SELL	-1,218	106.620	105.260	105.396	GBX -128,372	106.45 Profit of 1,288 on sale

Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of MRK

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer